Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Mediterranean is a four-day virtual conference featuring more than 80 dedicated company presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and broader regenerative medicine technologies. The meeting also includes over 50 panelists and featured speakers taking part in 13 in-depth sessions covering all aspects of cell and gene therapy commercialization.
Tune into a presentation by Charlie Silver, CEO of Mission Bio, who will provide an overview of the application of single-cell DNA and multi-omics analysis in the areas of cell therapy, gene therapy, and gene editing. The presentation will be available on-demand for the meeting attendees starting April 6.
